Profound Medical Corp Stock Buy Hold or Sell Recommendation
| PROF Stock | USD 5.62 0.07 1.23% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Profound Medical Corp is 'Strong Sell'. Macroaxis provides Profound Medical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding PROF positions. Check out Profound Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Profound and provide practical buy, sell, or hold advice based on investors' constraints. Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Execute Profound Medical Buy or Sell Advice
The Profound recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Profound Medical Corp. Macroaxis does not own or have any residual interests in Profound Medical Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Profound Medical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Profound Medical Trading Alerts and Improvement Suggestions
| Profound Medical had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 10.68 M. Net Loss for the year was (27.82 M) with profit before overhead, payroll, taxes, and interest of 8.02 M. | |
| Profound Medical Corp currently holds about 46.21 M in cash with (23.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.21. | |
| Profound Medical has a frail financial position based on the latest SEC disclosures | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: What are the technical indicators suggesting about Profound Medical Corp. - Expert Picks Updates Backed By Experts - jammulinksnews.com |
Profound Medical Returns Distribution Density
The distribution of Profound Medical's historical returns is an attempt to chart the uncertainty of Profound Medical's future price movements. The chart of the probability distribution of Profound Medical daily returns describes the distribution of returns around its average expected value. We use Profound Medical Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Profound Medical returns is essential to provide solid investment advice for Profound Medical.
| Mean Return | 0.27 | Value At Risk | -6.77 | Potential Upside | 5.94 | Standard Deviation | 4.30 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Profound Medical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Profound Stock Institutional Investors
| Shares | Ardsley Advisory Partners | 2025-03-31 | 295 K | Picton Mahoney Asset Management | 2025-03-31 | 253.4 K | Formula Growth Ltd | 2025-03-31 | 246 K | Thompson Davis & Co Inc | 2025-03-31 | 203.8 K | Bank Of America Corp | 2025-03-31 | 202.6 K | Bleichroeder Lp | 2025-03-31 | 183.3 K | Alyeska Investment Group, L.p. | 2025-03-31 | 160 K | Stonepine Capital Management Llc | 2025-03-31 | 139.9 K | Citadel Advisors Llc | 2025-03-31 | 72.3 K | Fidelity International Ltd | 2025-03-31 | 1.8 M | Gagnon Securities Llc | 2025-06-30 | 1.7 M |
Profound Medical Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 69.1M | (16.8M) | (20.6M) | (20.3M) | 28.7M | 30.1M | |
| Free Cash Flow | (20.9M) | (23.0M) | (25.8M) | (22.6M) | (23.5M) | (24.6M) | |
| Depreciation | 1.5M | 1.9M | 1.5M | 929K | 891.1K | 1.1M | |
| Other Non Cash Items | 890K | 132K | 2.7M | 828K | 299.9K | 284.9K | |
| Capital Expenditures | 32K | 191.4K | 350K | 593K | 0.0 | 1.96 | |
| Net Income | (21.6M) | (30.7M) | (28.7M) | (28.6M) | (27.8M) | (29.2M) | |
| End Period Cash Flow | 83.9M | 67.2M | 46.5M | 26.2M | 54.9M | 35.1M | |
| Change To Inventory | (2.1M) | (2.5M) | (1.9M) | 353K | 624.5K | 655.7K | |
| Investments | (250K) | (350K) | (593K) | (127K) | (114.3K) | (108.6K) | |
| Net Borrowings | (1.3M) | (9.6M) | (386K) | 6.9M | 6.2M | 6.5M | |
| Change To Netincome | 2.4M | 4.1M | 7.3M | 6.9M | 7.9M | 4.6M |
Profound Medical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Profound Medical or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Profound Medical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Profound stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.22 | |
β | Beta against Dow Jones | 0.38 | |
σ | Overall volatility | 4.07 | |
Ir | Information ratio | 0.04 |
Profound Medical Volatility Alert
Profound Medical Corp shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Profound Medical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Profound Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Profound Medical Fundamentals Vs Peers
Comparing Profound Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Profound Medical's direct or indirect competition across all of the common fundamentals between Profound Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Profound Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Profound Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Profound Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Profound Medical to competition |
| Fundamentals | Profound Medical | Peer Average |
| Return On Equity | -0.66 | -0.31 |
| Return On Asset | -0.39 | -0.14 |
| Profit Margin | (2.69) % | (1.27) % |
| Operating Margin | (4.26) % | (5.51) % |
| Current Valuation | 127.55 M | 16.62 B |
| Shares Outstanding | 30.05 M | 571.82 M |
| Shares Owned By Insiders | 17.34 % | 10.09 % |
| Shares Owned By Institutions | 47.44 % | 39.21 % |
| Number Of Shares Shorted | 614.11 K | 4.71 M |
| Price To Book | 3.25 X | 9.51 X |
| Price To Sales | 14.22 X | 11.42 X |
| Revenue | 10.68 M | 9.43 B |
| Gross Profit | 8.02 M | 27.38 B |
| EBITDA | (33.06 M) | 3.9 B |
| Net Income | (27.82 M) | 570.98 M |
| Cash And Equivalents | 46.21 M | 2.7 B |
| Cash Per Share | 2.21 X | 5.01 X |
| Total Debt | 5.12 M | 5.32 B |
| Debt To Equity | 0.02 % | 48.70 % |
| Current Ratio | 17.36 X | 2.16 X |
| Book Value Per Share | 1.69 X | 1.93 K |
| Cash Flow From Operations | (23.45 M) | 971.22 M |
| Short Ratio | 20.40 X | 4.00 X |
| Earnings Per Share | (1.21) X | 3.12 X |
| Target Price | 12.1 | |
| Number Of Employees | 142 | 18.84 K |
| Beta | 0.27 | -0.15 |
| Market Capitalization | 168.71 M | 19.03 B |
| Total Asset | 70.23 M | 29.47 B |
| Retained Earnings | (245.02 M) | 9.33 B |
| Working Capital | 62.5 M | 1.48 B |
| Current Asset | 9 K | 9.34 B |
| Current Liabilities | 761 K | 7.9 B |
Note: Acquisition by Menawat Arun Swarup of 12027 shares of Profound Medical at 4.73 subject to Rule 16b-3 [view details]
Profound Medical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Profound . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Profound Medical Buy or Sell Advice
When is the right time to buy or sell Profound Medical Corp? Buying financial instruments such as Profound Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Profound Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cash Cows Thematic Idea Now
Cash Cows
Entities with stable and reliable earnings or profits, which allows them to pay consistent dividends to their shareholders. The Cash Cows theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cash Cows Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Profound Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.21) | Revenue Per Share | Quarterly Revenue Growth 0.821 | Return On Assets | Return On Equity |
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.